$PROB ETAS WERE ADDED TO ALL THE PK PR AND RET0, RBC0, KSAI, KD, MCH ERR2 FIXED TO 0 $INPUT ID AMT TIME CMT DV DRUG ROUT RATE $DATA Simulated_EPO_dataset.csv IGNORE=I IGNORE=(DRUG=1) $SUBROUTINES ADVAN6 TOL=6 $EST MAXEVALS=9999 SIGDIGITS=2 PRINT=1 METHOD=1 INTERACTION NOABORT MSFO=EPO_FINAL_simulated_dataset.msf $COV PRINT=E ;*** PK PARAMETERS THETAS *** $THETA (0,2.4,10) ; D1 $THETA (0,0.045,5) ; KA $THETA (0,4.9,10) ; VC $THETA (0,0.3,0.6) ; CL $THETA (0,0.33,1) ; F1 $THETA 0 FIXED ; ALAG1 $THETA (0,8.2,20) ; C0 $THETA (0,0.06,1) ; K23 $THETA (0,0.1,1) ; K32 ;*** PD PARAMETERS *** $THETA (0,54,100) ; RET0 $THETA 0 FIXED ; TD3 $THETA (0,45,200) ; TP1 $THETA 0 FIXED ; TP2 $THETA 0 FIXED ; TP3 DUMMY $THETA (0,3,40) ; SC50 $THETA (0,0.04,1) ; SMAX $THETA (50,700,2000) ; KD $THETA (0,0.8) ; KSAI $THETA (0,4,20) ; RBO $THETA (0,34,100) ; MCH $OMEGA 0.5 ; ETAD1 $OMEGA 0.1 ; ETAKA $OMEGA 0.09 ; ETAVC $OMEGA 0.5 ; ETACL $OMEGA 0.1 ; ETAC0 $OMEGA 0.05 ; ETARET0 $OMEGA 0 FIXED ; TP1 $OMEGA 0 FIXED ; SC50 $OMEGA 0.8 ; ETASMAX $OMEGA 0 FIXED ; ETAKD $OMEGA 0.2 ; ETAKSAI $OMEGA 0.01 ;ETARBC0 $OMEGA 0.01 ;ETAMCH $SIGMA 0.04; ERRSD1 $SIGMA 0 FIXED; ERRSD2 $SIGMA 0.04; ERRSD3 $SIGMA 0.01; ERRSD4 $MODEL NCOMP=9 COM = (A1) ;COMPARTMENT #1 EPO SC COM = (A2) ;COMPARTMENT #2 EPO SERUM COM = (A3) ;COMPARTMENT #3 EPO TISSUE COM = (A4) ;COMPARTMENT #4 PRECURSOR 1 COM = (A5) ;COMPARTMENT #5 PRECURSOR 2 COM = (A6) ;COMPARTMENT #6 PRECURSOR 3 COM = (A7) ;COMPARTMENT #7 RET COM = (A8) ;COMPARTMENT #8 RBC COM = (A9) ;COMPARTMENT #9 HGB $PK ;*** PK PARAMETERS *** D1 = THETA(1)*EXP(ETA(1)) ;ZERO ORDER INFUSION DURATION KA = THETA(2)*EXP(ETA(2)) ;FIRST ORDER ABSORPTION RATE VC = THETA(3)*EXP(ETA(3)) ;VOLUME OF DISTRIBUTION OF SERUM COMPARTMENT CL = THETA(4)*EXP(ETA(4)) ; LINEAR CLEARANCE F1 = THETA(5) ; BIOAVAILABILITY ALAG1 = THETA(6) ; SHOULD FIXED TO ZERO C0 = THETA(7)*EXP(ETA(5)) ; EPO BASELINE K23 = THETA(8) ;TISSUE DISTRIBUTION CONSTANT K32 = THETA(9) ;TISSUE DISTRIBUTION CONSTANT ;*** PD PARAMETERS *** RR0 = THETA(10)*EXP(ETA(6)) ; RET0 TD3 = THETA(11) ; TR TP1 = THETA(12)*EXP(ETA(7)) ; TP1 TD2 = THETA(13) ; TP2 TD3 = THETA(14) ; TP3 DUMMY SC50 = THETA(15)*EXP(ETA(8)) ; SC50 SMAX = THETA(16)*EXP(ETA(9)) ; SMAX KD = THETA(17)*EXP(ETA(10)) ; KD KSAI = THETA(18)*EXP(ETA(11)) ; PROPORTIONAL COEFFICIENT RB0 = THETA(19)*EXP(ETA(12)) ; RBC BASELINE MCH = THETA(20)*EXP(ETA(13)) ; COEFFICIENT FOR HGB TR =TP1 TP3=TP1 TP2=TP1 TB=(RB0-RR0/1000)*TR*1000/RR0 ;RBC LIFESPAN ;*** INITIAL CONDITION FOR PK *** A_0(1) = 0 ;INITIAL CONDITION FOR SC COMPARTMENT A_0(2) = C0*VC ;INITIAL CONDITION FOR SERUM COMPARTMENT A_0(3) = C0*VC*K23/K32 ;INITIAL CONDITION FOR TISSUE COMPARTMET ;*** INITIAL CONDITION FOR PD *** RTOT0 = RR0*TP2/TR RC0 = RTOT0*C0/(KD+C0) SC0 = SMAX*RC0/(SC50+RC0) A_0(4) = RR0*TP1/(TR*SC0)*(1/2**5) A_0(5) = RR0*TP2/TR A_0(6) = RR0*TP3/TR A_0(7) = RR0 A_0(8) = RB0-RR0/1000 $DES ;*** EQUATIONS FOR PK *** RTOT = A(5) KEPO = CL*C0+RTOT0*KSAI*VC*C0/(KD+C0) ; ZERO ORDER PRODUCTION OF ENDOGENOUS EPO DADT(1) = -KA*A(1) ;EPO SC DADT(2) = KEPO+KA*A(1)-CL*A(2)/VC-K23*A(2)+K32*A(3)-RTOT*KSAI*VC*(A(2)/VC)/(KD+A(2)/VC) ;EPO SERUM DADT(3) = K23*A(2)-K32*A(3) ;EPO TISSUE ;*** EQUATIONS FOR PD *** C2 = A(2)/VC RC = RTOT*C2/(KD+C2) SC = SMAX*RC/(SC50+RC) KIN0 = RR0/TR*(1/2**5) DADT(4) = KIN0-1/TP1*SC*A(4) DADT(5) = 2**5*(1/TP1)*SC*A(4)-(1/TP2)*A(5) DADT(6) = (1/TP2)*A(5)-(1/TP3)*A(6) DADT(7) = (1/TP3)*A(6)-A(7)/TR DADT(8) = A(7)/(TR*1000)-A(8)/TB $ERROR IF (CMT.EQ.2) THEN IPRED=A(2)/VC Y = IPRED*(1 + EPS(1))+EPS(2) ELSE ENDIF IF (CMT.EQ.7) THEN IPRED=A(7) Y = IPRED*(1+EPS(3)) ELSE ENDIF IF (CMT.EQ.8) THEN ;RBC = A(8)+A(7)/1000 IPRED=A(8)+A(7)/1000 Y = IPRED*(1+EPS(4)) ELSE ENDIF IF (CMT.EQ.9) THEN ;HGB= MCH*RBC/10 IPRED=MCH*(A(8)+A(7)/1000)/10 Y = IPRED*(1+EPS(4)) ELSE ENDIF